医学档案

  • 国际标准期刊号: 1989-5216
  • 期刊 h 指数: 22
  • 期刊引用分数: 4.96
  • 期刊影响因子: 4.44
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Do Chloroquine and Hydroxychloroquine Treat COVID-19?

Bouhmou Ayoub*, Bzikha Reda, Bzikha Ilham and Bouchnafati Sanaa

Chloroquine is an anti-malarial and autoimmune disease drug, which has an antiviral activity. in vitro, the Chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV. Therefore, Chloroquine and Hydroxychloroquine are being studied for their potential treatment of coronavirus disease 2019. Those drugs are now recommended by the FDA, and multiple health organizations. This aims of this review is to explore the efficacy of the chloroquine and hydrochloroquine in the treatment of the novel COVID-19.